Results 51 to 60 of about 580 (130)

Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis

open access: yesPathophysiology
Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system whose heterogeneous clinical, radiological, and biological course has long resisted precise individual-level prediction.
Alireza Minagar, Mohammadali Sahraian
doaj   +1 more source

New Mechanisms and Therapeutic Targets in Systemic Lupus Erythematosus

open access: yesMedComm, Volume 6, Issue 6, June 2025.
Systemic lupus erythematosus (SLE) is a multiple organ involved autoimmune disorder with heterogeneous clinical manifestations. Despite hallmark features such as elevated type I interferon and the production of numerous autoantibodies, the underlying pathogenic mechanisms remain elusive.
Jingru Tian   +4 more
wiley   +1 more source

Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease

open access: yes, 2021
Bruton tyrosine kinase (Btk) is expressed in B-lymphocytes, myeloid cells and platelets, and Btk-inhibitors (BTKi) are used to treat patients with B-cell malignancies, developed against autoimmune diseases, have been proposed as novel antithrombotic ...
Philipp von Hundelshausen   +1 more
core   +1 more source

Oxidative Stress in Antigen Processing and Presentation

open access: yesMedComm – Oncology, Volume 4, Issue 2, June 2025.
Reactive oxygen species (ROS) play a crucial role in antigen processing and presentation, essential for linking innate and adaptive immunity. While balanced ROS levels promote immune function, excess ROS can disrupt antigen recognition, resulting in immune dysfunction.
Qinxia Chang   +9 more
wiley   +1 more source

Efficacy and Safety of Syk and BTK Inhibitors in Immune Thrombocytopenia: A Comprehensive Review of Emerging Evidence

open access: yesMediators of Inflammation, Volume 2025, Issue 1, 2025.
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a reduced platelet count, resulting in bleeding risks and compromised quality of life. Advances in understanding ITP pathogenesis have revealed critical roles for spleen tyrosine kinase (Syk) and Bruton’s tyrosine kinase (BTK) in Fc receptor (FcR)‐mediated immune pathways, which ...
Amirhossein Heidari   +7 more
wiley   +1 more source

Formulation, Optimization, and Evaluation of Fenebrutinib-Loaded Niosomal Gel for the Treatment of Rheumatoid Arthritis: A Novel Drug Delivery Approach [PDF]

open access: yes
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent synovial inflammation, cartilage degradation, and systemic complications.
Satinder Kakar   +2 more
core  

New Therapeutic Approaches for Haemorrhagic Shock [PDF]

open access: yes, 2022
Trauma is one of the leading causes of death and disability, affecting 6 million people annually worldwide. Haemorrhagic shock (HS), which causes hypoperfusion of organs and ischaemia, accounts for ~40% of trauma-associated deaths.
Patel, N
core   +1 more source

Next generation Bruton's tyrosine kinase inhibitors – characterization of in vitro potency and selectivity

open access: yes
Bruton's tyrosine kinase (BTK) mediates B cell receptor and Fc receptor signaling and is a key regulator of autoimmunity and allergy. A series of novel BTK inhibitors (BTKi) are currently in development for non-oncologic indications with covalent ...
Cenni, Bruno   +2 more
core   +1 more source

ePoster

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Additional file 1 of Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

open access: yes
Supplementary Material 1.
Langlois, Julie   +12 more
openaire   +1 more source

Home - About - Disclaimer - Privacy